The attenuated invasive capacity of GBM tumors following treatment with CLOVA cocktail was associated with decrease in activating phosphorylation of (pFAKY397 and pFAKY861; Supplementary Figure 5) and with alteration in subcellular localization of active Rac1 in tumor cells (Figure 3C). This evidence concerns the gene RAC1 and glioblastoma.